Imaging Guided Patient Selection for Interventional Revascularization Therapy "START"


Phase 4 Results N/A

Summary of Purpose

The primary objective of this clinical evaluation is to determine the safety and effectiveness of the Penumbra System in a stroke cohort who presents within 8 hours from symptom and with a known core infarct volume at admission. The secondary objective is to determine if there is a correlation between infarct volume and functional outcome in treated patients at 90 days post-procedure.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 September 2016.

1 Sep 2009 18 Aug 2009 1 Sep 2016 1 Sep 2016 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment